| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.041 | 0.4 |